I understand your point. I have tried to think of several situations as to why they don't PR more than they are currently do and have listed them below -
Despite sincere intentions in providing expected updates to trials they have all slipped. They would rather wait and provide updates when they have something meaningful to go public with. They are open to ridicule for providing updates on no news. They are open to ridicule for not providing any updates - but not by Woodford or large shareholders who have access.
The clinical results or trials have been subject to interference and they are on news lock down, pending an investigation.
The clinical results are not demonstrating the expected efficacy and are keeping quiet to continue a major fraud.
The clinical results are being reviewed as we speak and we are awaiting an update when the process has been completed. With the intention of early approval.
Linda does not care about retail shareholders and as such they are always the last to know anything.
Linda does care about all shareholders and holds the belief that it is in your interest at this point in time to stay silent on a number of issues that will be addressed as a matter of routine at the AGM on the 18th of December (eight days time)
..............................................................
My 3rd point would mean that she is intentionally withholding clinical data from the markets that have resulted in significant losses to investors and would be subject to legal action. - Very unlikely that she would do that to herself and especially after the very recent fund raising she completed with NW. It also involves way to many medical experts like Dr Linda Liau as well as external audits and trial centres to continue a fraud for any length of time. Notwithstanding the very sensitive subject of patients hopes for a cure. Its a non starter for me.
My 5th point is a more likely to raise the temp on this board. Retail investors are in every sense very high maintenance for low value in terms of the bigger picture. She has to manage a very subtle line between pandering to their every request and shielding herself from the daily request for information and updates. In a nutshell she needs to get on with running the business and takes a view that all shareholders are welcome but there is a limit to which she can respond to every single request. It's a fine line and some could argue that she is slightly off line from a retail shareholders perspective. To mitigate this I personally think she is seriously busy dealing with getting us to approval and fighting off hostile hedge funds intent on wiping as all out.
My 1st, 2nd, 4th, 5th and 6th points are all possible, I don't think my 3rd is likely. Which is why I am Long.
Please feel free to add your alternative opinions.
AI
Market Data 
Markets 
